Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2020-08-18 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
申万宏源证券承销保荐有限责任公司关于公司首次公开发行股票并在创业板上市之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to "Listing Sponsorship Letter" or "Sponsorship Document" related to the company's initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It is issued by the underwriting and sponsoring securities company for the IPO of 康泰医学系统（秦皇岛）股份有限公司. The content includes detailed information about the issuer, core technologies, business overview, financial data, risk factors, and specifics about the securities issuance. This type of document is a formal sponsorship report required for IPOs in China, which is distinct from an annual report or earnings release. It is not a simple announcement or a proxy statement but a comprehensive document supporting the IPO process. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to the company's capital raising and listing activities.
2020-08-18 Chinese
北京市中伦律师事务所关于公司首次公开发行股票并在深圳证券交易所创业板上市的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's initial public offering (IPO) and listing on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It discusses the legal compliance, approvals from regulatory bodies such as the China Securities Regulatory Commission (CSRC), and the qualifications of the company for the IPO. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to capital market activities. It is not an announcement of a report but a standalone legal opinion document. This fits best under the category of Capital/Financing Update (CAP), as it relates to the company's fundraising and capital market listing activities.
2020-08-18 Chinese
首次公开发行股票并在创业板上市发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行结果公告" which translates to "Issuance Results Announcement" for the company's initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It details the final issuance price, number of shares issued, subscription statistics, allotment, and underwriting information. The document is relatively short (2691 characters) and focuses on the results of the share issuance rather than the issuance process or financial statements. This matches the description of a Capital/Financing Update (CAP) as it provides updates on the company's fundraising and capital structure changes. It is not an Annual Report, Earnings Release, or Regulatory Filing. Therefore, the correct classification is CAP with high confidence.
2020-08-13 Chinese
首次公开发行股票并在创业板上市招股说明书
Share Issue/Capital Change Classification · 95% confidence The document is a detailed prospectus (招股说明书) for an initial public offering (IPO) of 康泰医学系统（秦皇岛）股份有限公司 on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It includes extensive information about the stock issuance, risk factors, company background, financial data, governance, and management analysis. The document contains substantive financial data, management discussion, risk disclosures, and detailed company information typical of an IPO prospectus. This type of document is not an annual report, earnings release, or a simple announcement but a comprehensive offering document for new stock issuance. According to the filing definitions, this corresponds to a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues and capital changes. The document length (15,000 characters) and content confirm it is the actual prospectus, not just an announcement or summary. Therefore, the correct classification is SHA with high confidence.
2020-08-13 Chinese
首次公开发行股票并在创业板上市网下发行初步配售结果公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial offline allotment results for the initial public offering (IPO) and listing of 康泰医学系统（秦皇岛）股份有限公司 on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It includes specifics about the number of shares issued, pricing, subscription details, allotment ratios, investor categories, and instructions for payment. The document references regulatory approvals from the Shenzhen Stock Exchange and the China Securities Regulatory Commission (CSRC). It is not a financial report like an annual or interim report, nor is it a transcript, audit report, or management information. It is also not a proxy statement or voting result announcement. The content is focused on the allotment results and subscription instructions for the IPO shares, which fits the category of Capital/Financing Update (CAP) as it relates to fundraising and issuance of new shares. The document length is substantial and contains detailed allotment data, not just a brief announcement or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-08-11 Chinese
首次公开发行股票并在创业板上市网上摇号中签结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement of the lottery results for the online subscription of shares in the initial public offering (IPO) of 康泰医学系统（秦皇岛）股份有限公司. It details the subscription process, payment obligations, and the specific winning numbers for the share allocation. The document is short (2044 characters) and focuses on the results of the share allocation lottery rather than financial data or report content. It is not a financial report, earnings release, or management discussion. It is an announcement related to capital issuance and share allocation in an IPO context. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-08-11 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.